DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20175023

Maternal and perinatal outcome in eclampsia complicated by posterior reversible encephalopathy syndrome; a three years’ experience in a tertiary care hospital

Shashikala Karanth Karanth, Kavitha Gonsalves, Sheela C. N., Reena Mathew, G. R. K. Sarma, Babu Phillip, . Sumithra

Abstract


Background: PRES can be associated with number of medical conditions and was observed frequently in patients with preeclampsia and eclampsia. Neuroimaging is important for the diagnosis of PRES. Study was conducted to find out the maternal and perinatal outcome in patients with eclampsia complicated by posterior reversible encephalopathy syndrome (PRES).

Methods: This is a retrospective study done at St. Johns Medical College Bangalore, between October 2013 and October 2016. We reviewed case records of all the patients with eclampsia who underwent neuro imaging studies and a diagnosis of PRES was made. The maternal and perinatal outcomes in these women were studied

Results: In the past three years we had 55 cases of eclampsia who underwent neuroimaging studies for persistent neurological symptoms after 24 hours of MgSO­4 treatment. Of these women 30 were diagnosed to have PRES. In the present study PRES was common in multiparous women and more in patients with antepartum eclamptic women. Mean age at diagnosis of PRES was 26±5.1 years. Common presenting symptoms were headache (93.3%) and vomiting (53.3%). The mean SBP/DBP was 180/110 mmHg. All patients who had recurrent seizures were controlled with MgSO­4 alone. 53.3% of our patients had eclampsia related complications and 36.7% required ICU care. There were 3 maternal deaths (10%). Perinatal mortality was 20%.

Conclusions: Neuroimaging in eclamptic patients with persistent neurological symptoms could help in early diagnosis of PRES and multidisciplinary approach in management could contribute significantly in reducing the maternal mortality and morbidity.


Keywords


Eclampsia, MgSO4, MRI/CT, PRES

Full Text:

PDF

References


Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al. A reversible posterior leukoencephalopathy syndrome. Engl J Med. 1996;334:494-500.

Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14.

Sraykov D, Schwab S. Posterior reversible encephalopathy syndrome. J Intensive Care Med. 2012;27:11-24.

Lee VH, Wijdicks EF, Manno EM. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65:205-10.

Matsuda H, Sakaguchi K, Shibasaki T. Cerebral edema on MRI in severe preeclamptic women developing eclampsia. J Perinat Med. 2005;33:199-205.

Mayama M, Uno K, Tano S, Yoshihara M, Ukai M, Kishigami Y, et al. Incidence of posterior reversible encephalopathy syndrome in eclamptic and women with preeclampsia with neurologic symptoms. Am J Obstet Gynecol. 2016;215:239.e1-239.e15.

Junewar V, Verma R, Sankhwar PL, Garg RK, Singh MK., Malhotra HS, et al. Neuroimaging features and predictors of outcome in eclamptic encephalopathy: a prospective observational study. Am J Neuroradiol. 2014;35:1728-34.

Brewer J, Owens MY, Wallace K. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol. 2013;208:68.e1-468.e6.

Bembalgi S, Kamate V, Shruthi KR. A Study of eclampsia cases associated with posterior reversible encephalopathy syndrome. J Clin Diagn Res. 2015;9(7).

Rodrigo P, Paul EM, Joseph V. Posterior reversible encephalopathy syndrome: a review. Crit Care and Shock.2009;12:135-43.

Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043-9.

McKinney AM, Short J, Truwit CL. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am Roentgenol. 2007;189:904-12.

Nobi PN. Hajong A. Eclampsia in India through the decades. J Obstet Gynaecol Ind. 2016;66S(S1):S172-6.

Fisher N, Saraf S, Egbert N, Homel P, Stein EG, Minkoff. Clinical correlates of posterior reversible encephalopathy syndrome in pregnancy. J Clin Hypertension. 2016;18(6):522-7.

Mavani PJ, Oza HV, Vohra HM. Posterior Reversible Encephalopathy Syndrome (PRES) In pregnancy. Int J Cur Res Rev. 2015;7(20):41.

Jamie MN, Shervin E. Late postpartum eclampsia with posterior reversible encephalopathy syndrome. Hospital Physician. 2007;43(6):45-9.

Vinod SP, Dhamangaonkar BR, Pattanshetti RC, Patil MM. Posterior reversible encephalopathy syndrome in early postpartum women: a case report. J Clin Diag Res. 2014;8(4):RD01.

Chhabra A, Jagtap S. Postpartum seizures with posterior reversible encephalopathy syndrome following cesarean delivery for triplets. J Obstet Anaesth Crit Care. 2014;4(1):50-2.

Schwartz RB, Feske SK, Polak JF. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiol. 2000;217:371.

Demir BC, Ozerkan K, Ozbek SE, Yildirim EN, Ocakoglu G. Comparison of magnesium sulfate and mannitol in treatment of eclamptic women with posterior reversible encephalopathy syndrome. Arch Gynecol Obstet. 2012;286:287-93.

Roth C, Ferbert A. Posterior reversible encephalopathy syndrome: long-term follow-up. J Neurol Neurosurg Psychiatry. 2010;81:773-7.

Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?. Neuroradiol. 2009;51(6):373-83.

Wagner SJ, Acquah LA, Lindell EP, Craici IM, Wingo MT, Rose CH, et al. Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clin Proc. 2011;86(9):851-6.

Zeeman GG, Cunningham FG. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol. 2014;210:378-9.

Demirtas O, Gelal F, Vidinli BD, Demirtas LO, Uluc E, Baloglu A. Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. Diagn. Interv Radiol. 2005;11:189-94.

Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg. 2010;112:886-91.

Dahmus MA, Barton JR, Sibai BM. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol. 1992;167:935-41.

Pula JH, Eggenberger E. Posterior reversible encephalopathy syndrome; current opinion. Ophthalmol. 2008;19(6):479-84.

Xuan H, Jinfeng X, Zao C, Guoliang L, Hong J. Posterior reversible encephalopathy syndrome with involvement of the cervical cord and medulla: a case report. J Clin Diag Res. 2015;9(1):CD01.

Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, et al. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in pediatric patients with nephrotic syndrome. Nephrol Dial Transplant. 2008;23(8):2531-6.

Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Applied Physiol. 2011;110(2):329-39.

American College of Obstetricians and Gynecologists. Emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. ACOG Committee Opinion no. 514. 2011.

Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke. 2009;40:1169-75.

Narbone MC, Musolino R, Granata F. PRES: posterior or potentially reversible encephalopathy syndrome? Neurol Sci; 2006;27:187-9.

Servillo G, Striano P, Striano S, Tortora F, Boccella P, De Robertis E, et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med. 2003;29(12):2323-26.

Liman TG, Bohner G, Heuschmann PU, Scheel M, Endres M, Siebert E. Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases. Eu J Neurol. 2012;19(7):935-43.

Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009;30(7):1371-9.

Martin JN Jr, Owens MY, Keiser SD. Standardized Mississippi protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy. 2012;31:79-90.

Sighal AB, Kimberly WT, Schaefer PW, Hedley-Whyte ET. Case records of Massachusetts General Hospital. A 36-years-old woman with headache, hypertension, and seizure 2 weeks postpartum. N Engl J Med. 2009;360(11):1126-37.

Sargin MA, Tug N, Karadogan FO, Yassa M, Guner D. Posterior reversible encephalopathy syndrome and maternal death in an obstetric patient: case report. Hong Kong J Emerg Med. 2016;23(5):297.

Kurdoglu Z, Cetin O, Sayın R, Dirik D, Kurdoglu M, Kolusarı A, et al. Clinical and perinatal outcomes in eclamptic women with posterior reversible encephalopathy syndrome. Arch Gynecol Obstet. 2015;292:1013-8.

Camara-Lemarroy CR, Escobedo-Zúñiga N, Villarreal-Garza E, García-Valadez E, Góngora-Rivera F, Villarreal-Velázquez HJ. Posterior reversible leukoencephalopathy syndrome (PRES) associated with severe eclampsia: Clinical Biochem Features Pregnancy Hypertens. 2017;7:44-9.